New England Biolabs (United States)
New England Biolabs is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
71%
Total
Publications
1.8K
Total Open
Publications
1.3K
Total
Citations
110K
Open Access
Percentage
71%
Total
Publications
1.8K
Total Open
Publications
1.3K
Total
Citations
110K
Breakdown
Publisher Open
15%
Both
42%
Other Platform Open
12%
Closed
31%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 67%
649
Hybrid 18%
172
No Guarantees 15%
152
Other Platform Open
Domain 76%
701
Other Internet 22%
207
Institution 19%
179
Public 7%
67
Preprint 1%
12
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 697 |
DOI | Other Internet | 202 |
Figshare | Public | 68 |
Europe PMC | Domain | 68 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 57 |
DASH - Digital Access to Scholarship at Harvard | Institution | 34 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 27 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 9 |
DANS - Data Archiving and Networked Services | Institution | 9 |
Research Square | Preprint | 8 |